Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review
other
OA: closed
public-domain-us
Abstract
There is growing evidence suggesting cannabinoids may provide suitable alternatives to conventional treatments in an increasing number of clinical settings. This review evaluates how cannabinoids are used to treat certain benign urological pathologies and to clarify the clinical value of this data. This review includes 62 papers and was undertaken per PRISMA's guidelines, it evidences the therapeutic potential of cannabinoids in the management of specific benign urological diseases, most notably neurogenic bladder dysfunction (clinical studies), renal disease (animal studies), and interstitial cystitis (animal studies). However, whilst cannabinoids are increasingly used, they cannot be considered reliable alternatives to more recognised treatments.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (42)
- doi:10.1007/s00345-003-0331-6 via crossref
- doi:10.1046/j.1464-410x.2002.02908.x via crossref
- doi:10.1016/s0022-5347(05)64261-9 via crossref
- doi:10.1111/bcpt.12577 via crossref
- doi:10.1007/s11910-018-0814-x via crossref
- doi:10.1056/nejmra1402309 via crossref
- doi:10.1054/plef.2001.0341 via crossref
- doi:10.1038/372619a0 via crossref
- doi:10.1111/bcp.13618 via crossref
- doi:10.4103/0970-1591.60440 via crossref
- doi:10.1007/978-3-030-21737-2_8 via crossref
- doi:10.1093/bja/81.1.77 via crossref
- doi:10.1007/s40265-018-0996-1 via crossref
- doi:10.4172/2161-0932.1000163 via crossref
- doi:10.1074/jbc.m109.050187 via crossref
- doi:10.1002/nau.22442 via crossref
- doi:10.1016/j.kint.2018.01.024 via crossref
- doi:10.1159/000494512 via crossref
- doi:10.3390/ijms19030833 via crossref
- doi:10.1016/s0014-2999(98)00392-6 via crossref
- doi:10.1089/ars.2017.7144 via crossref
- doi:10.1523/jneurosci.16-20-06601.1996 via crossref
- doi:10.1007/3-540-26573-2_25 via crossref
- doi:10.1212/wnl.0000000000000363 via crossref
- doi:10.1001/jamanetworkopen.2018.3485 via crossref
- doi:10.1177/2054358119828391 via crossref
- doi:10.1111/j.1526-4637.2006.00085.x via crossref
- doi:10.1158/0008-5472.can-07-2785 via crossref
- doi:10.1016/j.juro.2014.04.008 via crossref
- doi:10.1007/s12031-014-0453-x via crossref
- doi:10.1016/j.bbr.2018.06.030 via crossref
- doi:10.3389/fnsys.2018.00017 via crossref
- doi:10.1097/00000542-200103000-00023 via crossref
- doi:10.1523/jneurosci.2657-04.2004 via crossref
- doi:10.1111/j.1476-5381.2011.01327.x via crossref
- doi:10.1186/1744-8069-7-31 via crossref
- doi:10.1124/jpet.104.074864 via crossref
- doi:10.1007/s00210-006-0073-2 via crossref
- doi:10.5489/cuaj.2268 via crossref
- doi:10.1016/j.urology.2017.02.029 via crossref
- doi:10.1097/01.aog.0000558760.12370.22 via crossref
- doi:10.1007/s00192-006-0086-x via crossref
Source provenance
- crossref
- last seen: 2026-06-02T01:00:48.309401+00:00
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- pubmed
- last seen: 2026-05-13T22:21:36.268089+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine